The net clinical benefit of anticoagulants for atrial fibrillation (AF)—one of the most important causes of irregular heartbeats and a leading cause of stroke—decreases with age, as the risk of death from other factors ...
Nov 11, 2019
0
162
Nearly 98% percent of people prescribed direct-acting oral anticoagulants such as apixaban used over-the-counter products. Of those, 33% took at least one such product that, in combination with the anticoagulants, could cause ...
Oct 28, 2019
0
3
Anticoagulants and antiplatelet drugs, which are blood thinners such as warfarin and aspirin, are commonly taken to reduce the risk of potentially fatal blood clots, but they carry an increased risk of gastrointestinal bleeding.
Sep 5, 2019
0
1
(HealthDay)—For patients with subcentimeter colorectal polyps receiving oral anticoagulants, continuous administration of anticoagulants (CA) with cold snare polypectomy (CSP) is noninferior to periprocedural heparin bridging ...
Jul 17, 2019
0
0
(HealthDay)—Non-vitamin K oral anticoagulants (NOACs) have a superior benefit-risk profile to that of vitamin K antagonists (VKAs) for patients with early-stage chronic kidney disease (CKD), according to a review published ...
Jul 16, 2019
0
1
Atrial fibrillation (AF) is linked to an increased risk of dementia, even in people who have not suffered a stroke, according to the largest study to investigate the association in an elderly population.
Jun 18, 2019
0
8
(HealthDay)—Black patients with atrial fibrillation are less likely to receive direct-acting oral anticoagulants (DOACs) compared with white patients, even after controlling for clinical and sociodemographic features, according ...
Dec 21, 2018
0
0
A Vanderbilt University Medical Center (VUMC) study published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor ...
Dec 4, 2018
0
4
Black patients with atrial fibrillation are significantly less likely to receive oral anticoagulants—particularly newer, more effective versions—than white and Hispanic patients, according to a new study published today ...
Nov 28, 2018
0
0
Researchers of the Consejo Superior de Investigaciones Científicas (CSIC), the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and CIBER Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) have developed ...
Nov 27, 2018
0
0
